Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6

被引:54
|
作者
Kuropatwinski, KK
DeImus, C
Gearing, D
Baumann, H
Mosley, B
机构
[1] ROSWELL PK CANC INST,DEPT MOL & CELLULAR BIOL,BUFFALO,NY 14263
[2] IMMUNEX CORP,SEATTLE,WA 98101
[3] MILLENNIUM PHARMACEUT INC,CAMBRIDGE,MA 02139
关键词
D O I
10.1074/jbc.272.24.15135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncostatin M (OSM), leukemia inhibitory factor (LIF), and interleukin-6 (IL-6) induce expression of a similar set of acute phase plasma protein genes in hepatic cells, The redundant action of these cytokines has been ascribed to the involvement of the common signal-transducing receptor subunit, gp130, in combination with cytokine-specific, ligand-binding subunits, To define the specificity of the signal transduction by the LIF/OSM receptor (a heterodimer of gp130 and LIF receptor (LIFR)) and the OSM-specific receptor (a heterodimer of gp130 and OSM receptor (OSMR)), we reconstituted the receptor function by transfection into receptor-negative Hep3B hepatoma cells, Both receptors activate DNA binding activity of STAT1, -3, and -5B and induce gene transcription through IL-6-responsive elements, The signaling competent cytoplasmic domain regions of OSMR and LIFR were defined by the analysis of progressive carboxyl-terminal deletion constructs, The 36 residue carboxyl-terminal region containing the distal box 3 sequence motif of OSMR is required for signal transduction by the OSM-specific receptor. In contrast, signaling by LIFR did not display the same requirement for receptor domains and was not strictly dependent on the box 3 elements, The signaling by endogenous LIF and OSM receptors differed from that by IL-6R by the prominent activation of STATE as shown in the mouse hepatoma cell line, Hepa-1. The data suggest that the signaling specificity of the receptors for the three cytokines is determined by the composition of the cytoplasmic domains associated in the signal-competent receptor complex and that the signaling is not identical among these cytokine receptors.
引用
收藏
页码:15135 / 15144
页数:10
相关论文
共 50 条
  • [1] Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M
    Hartner, A
    GoppeltStruebe, M
    Hocke, GM
    Sterzel, RB
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (06) : 1754 - 1760
  • [2] Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal osteoblastic cells
    Bellido, T
    Stahl, N
    Farruggella, TJ
    Borba, V
    Yancopoulos, GD
    Manolagas, SC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02): : 431 - 437
  • [3] Regulation of oligodendrocyte cell survival and differentiation by ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and interleukin-6
    Vos, JP
    Gard, AL
    Pfeiffer, SE
    [J]. PERSPECTIVES ON DEVELOPMENTAL NEUROBIOLOGY, 1996, 4 (01) : 39 - +
  • [4] Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M in cultured mesangial cells.
    Hartner, A
    GoppeltStrube, M
    Sterzel, RB
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1819 - 1820
  • [5] Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor
    Timmermann, A
    Pflanz, S
    Grötzinger, J
    Küster, A
    Kurth, I
    Pitard, V
    Heinrich, PC
    Müller-Newen, G
    [J]. FEBS LETTERS, 2000, 468 (2-3) : 120 - 124
  • [6] The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
    Okamoto, H
    Yamamura, M
    Morita, Y
    Harada, S
    Makino, H
    Ota, Z
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (06): : 1096 - 1105
  • [7] ONCOSTATIN-M IS A MEMBER OF A CYTOKINE FAMILY THAT INCLUDES LEUKEMIA-INHIBITORY FACTOR, GRANULOCYTE COLONY-STIMULATING FACTOR, AND INTERLEUKIN-6
    ROSE, TM
    BRUCE, AG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8641 - 8645
  • [8] Signalling of interleukin-6 type cytokines via gp130, leukemia inhibitory factor (LIF) receptor and oncostatin M receptor
    Behrmann, I
    Hermanns, HM
    Haan, C
    Kortylewski, M
    Radtke, S
    Greiser, J
    Heinrich, PC
    [J]. EUROPEAN CYTOKINE NETWORK, 2000, 11 (03) : 491 - 492
  • [9] Expression of interleukin-6, leukemia inhibitory factor and their receptors by colonic epithelium and pericryptal fibroblasts
    Rockman, SP
    Demmler, K
    Roczo, N
    Cosgriff, A
    Phillips, WA
    Thomas, RJS
    Whitehead, RH
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (09) : 991 - 1000
  • [10] Interleukin-6, leukemia inhibitory factor and oncostatin M stimulate bone resorption and regulate the expression of RANKL, OPG and RANK in mouse calvariae
    Persson, E
    Palmquist, P
    Conaway, HH
    Lundberg, P
    Lerner, UH
    [J]. BONE, 2001, 28 (05) : S162 - S162